top of page
brush hero.jpg

About

Paint is committed to advancing its delivery technology and building a pipeline of tissue-targeted therapeutics. The modular PAINTR™ discovery platform has identified targeted delivery motifs for multiple tissues.

team hero web.jpg

Company Overview

Meet The Team

With over 20 years of collaborative experience, the Paint team brings unparalleled expertise in drug discovery and development. Uniquely positioned to develop groundbreaking technologies like PulmoPaint™, CerebroPaint™, and GastroPaint™, we are revolutionizing how medicines are delivered and retained in specific tissues.

bill.jpg

Bill Reddick

Co-founder & CEO

View Bio

other.jpg

Eric Springman, PhD

Co-Founder &  COO

View Bio

paint hero.jpg

Frank Guarnieri, PhD

Co-Founder, & CSO

View Bio

woman.jpg

Mariah Stewart, PhD

Scientific Program Advisor

View Bio

IMG_5675.jpg

Ron Sarkar, PhD, MBA

BD Consultant

View Bio

dani paint.jpg

Dani Stoltzfus, PhD

R&D Consultant

footer.jpg

© 2025 Paint Therapeutics. All Rights Reserved.

splash drop hero.jpg
bottom of page